company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24419000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24419000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2981000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2981000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21438000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12640000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4570000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17210000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4228000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,157000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,56000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4127000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4126000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4126000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4126000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52436681.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53103623.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51600000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 17:01:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20127000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20127000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2499000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2499000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17628000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11104000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4602000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15706000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1922000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,130000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1892000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1891000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1891000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1891000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52595214.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53306449.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47300000.0
Depomed Inc,ASRT,,0001005201,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:57:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83101000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83101000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1635000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1635000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81466000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17503000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5154000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-40000000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-17343000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,98809000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98819000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98817000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98817000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98817000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53353287.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55754051.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.77
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53400000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:44:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21218000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21218000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2140000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2140000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19078000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21031000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4043000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25074000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5996000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,357000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,318000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5678000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5679000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5679000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-97000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5582000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54056064.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54056064.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50700000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 17:02:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16522000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16522000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1150000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1150000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15372000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21474000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3208000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24682000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9310000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,410000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,386000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8924000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-348000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8576000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8576000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,187000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8763000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55371954.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55371954.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58400000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 16:34:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12132000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12132000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,619000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,619000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11513000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21536000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2782000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24318000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12805000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-289000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-290000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13095000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,741000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13836000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13836000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-90000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13746000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54562820.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56089796.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54400000.0
Depomed Inc,ASRT,,0001005201,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16835000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16835000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,518000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,518000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16317000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21773000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3482000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25255000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8938000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,143000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8795000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8804000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8804000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-93000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8711000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55554579.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55554579.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54400000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:05:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14110000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14110000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1442000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1442000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12668000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25021000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3525000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28651000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15983000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,204000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,204000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15779000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15780000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15780000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15780000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55786617.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55786617.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56400000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:05:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33282000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33282000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1763000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1763000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31519000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26832000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5270000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,958000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33060000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1541000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,96000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,57000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1484000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1495000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1495000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1495000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56039186.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56039186.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 16:58:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26589000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26589000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2316000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2316000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24273000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24020000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3185000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,959000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28164000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3891000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,77000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3814000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-112000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3702000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3702000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,93000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3795000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55892563.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55892563.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56200000.0
Depomed Inc,ASRT,,0001005201,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26174000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26174000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1484000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1484000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24690000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25963000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3298000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,962000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30223000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5533000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,116000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-46000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5579000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-99000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5480000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5480000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5480000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56460829.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56460829.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54800000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:35:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29963000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29963000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1688000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1688000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28275000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25368000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1412000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,963000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27743000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,532000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,538000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,478000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,478000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,478000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56562433.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57142343.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:45:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37460000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37460000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1751000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1751000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35709000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26374000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1339000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1158000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28871000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6838000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,285000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-258000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6580000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6514000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6514000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6514000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56818883.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57661212.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59200000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:28:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40608000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40608000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2168000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2168000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38440000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27471000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2024000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1465000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30960000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7480000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4958000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,519000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4439000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3041000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-38760000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41801000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41801000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41801000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56736009.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57543979.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57000000.0
Depomed Inc,ASRT,,0001005201,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76544000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,76544000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3702000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3702000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72842000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32517000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2042000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2539000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37098000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35744000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6005000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5978000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29766000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11827000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17939000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17939000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17939000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57545862.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59923083.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57900000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:04:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67732000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67732000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4675000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4675000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63057000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32573000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1397000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2542000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36512000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26545000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5519000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5499000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21046000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8300000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12746000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12746000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12746000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58105902.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60430456.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57900000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 16:59:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51485000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51485000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3523000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3523000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47962000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27078000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1644000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2540000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31262000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16700000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4364000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1910000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6251000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10449000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3995000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6454000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6454000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6454000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58567603.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60864107.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58700000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:00:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,194602000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,194602000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3246000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3246000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,191356000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28958000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2033000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2540000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33531000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,157825000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8033000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,145000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1910000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5978000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,151847000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57224000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94623000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94623000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94623000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58292633.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66307364.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.43
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58300000.0
Depomed Inc,ASRT,,0001005201,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32203000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32203000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3112000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3112000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29091000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34542000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1858000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2540000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38940000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9849000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6022000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5965000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15814000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4181000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11633000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11633000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11633000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59560873.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59560873.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58200000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 13:42:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94504000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94504000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22865000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22865000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71639000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57408000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4714000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,26731000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88853000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17214000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22078000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22017000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39231000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-17578000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21653000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21653000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21653000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60100000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60100000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59991934.0
Depomed Inc,ASRT,,0001005201,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:27:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104856000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104856000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20914000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20914000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83942000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49065000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4629000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27013000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80707000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3235000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22634000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,62000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22572000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19337000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7552000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11785000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11785000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11785000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58900000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58900000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60320369.0
Depomed Inc,ASRT,,0001005201,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 17:30:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,111172000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,111172000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21007000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21007000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90165000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58337000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61240000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27060000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-29900000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,116737000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26572000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22702000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,419000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22283000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48855000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-18188000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30667000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30667000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30667000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60100000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60100000.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60116530.0
Depomed Inc,ASRT,,0001005201,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104780000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104780000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23549000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23549000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81231000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52559000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5949000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27037000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85545000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4314000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22727000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22597000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26911000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5994000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20917000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20917000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20917000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61500000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61500000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60898186.0
Depomed Inc,ASRT,,0001005201,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 21:37:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,116682000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,116682000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20965000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20965000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,95717000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51903000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7116000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27037000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,86056000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9661000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25925000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25858000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16197000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5656000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10541000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10541000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10541000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62000000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62000000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61166044.0
Depomed Inc,ASRT,,0001005201,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:07:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,110524000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,110524000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20243000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20243000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90281000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51574000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10412000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27037000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,89023000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1258000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20307000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20194000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18936000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6042000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12894000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12894000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12894000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61400000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61400000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61422015.0
Depomed Inc,ASRT,,0001005201,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 21:10:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,123911000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,123911000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22657000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22657000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101254000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48462000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9154000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25734000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83350000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17904000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20537000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,175000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20362000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2458000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41892000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44350000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44368000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44368000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61297000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61297000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61297000.0
Depomed Inc,ASRT,,0001005201,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,90447000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,90447000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17774000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17774000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72673000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48519000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5084000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25735000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79338000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6665000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20124000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,250000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19874000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26539000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,202000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26741000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26741000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26741000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62128862.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62128862.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62200000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:54:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100457000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100457000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19725000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19725000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80732000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50010000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5614000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25735000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3441000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84800000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4068000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23122000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,282000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22840000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26908000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-249000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26659000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26659000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26659000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62531696.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62531696.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62000000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 15:07:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,95413000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,95413000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17396000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17396000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78017000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48850000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1761000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25734000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,434000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76779000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1238000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17815000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17743000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16505000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-513000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15992000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15992000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15992000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62997000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62997000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64000000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 18:07:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94407000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94407000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17703000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17703000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76704000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48317000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26159000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25541000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9372000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109389000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32685000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18429000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-604000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17745000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1288000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33973000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-869000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33104000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33104000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33104000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62702000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62702000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62702000.0
Depomed Inc,ASRT,,0001005201,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,128404000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,128404000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12044000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12044000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,116360000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29033000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1528000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25444000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9017000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65022000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51338000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18068000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,229000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17839000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33499000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-325000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33824000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33824000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33824000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63503000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81877000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63800000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 09:22:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63274000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63274000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2753000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2753000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60521000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31308000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2180000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25444000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5814000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64746000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4225000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17010000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,67000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16943000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21168000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-120000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21048000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21048000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21048000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63719000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63719000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63800000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:06:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,77493000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,77493000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2975000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2975000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74518000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33409000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2127000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25443000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3911000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64890000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9628000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17190000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62677000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,45487000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55115000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6845000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48270000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48270000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48270000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63917000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82690000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63500000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 08:39:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42599000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42599000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,704000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,704000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41895000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25468000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2207000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25443000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1859000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54977000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13082000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16613000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,224000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16389000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29471000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5300000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24171000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24138000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24138000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63794000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64208000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63794000.0
Depomed Inc,ASRT,,0001005201,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57929000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57929000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2575000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2575000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55354000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25045000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1793000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25444000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52282000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3072000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16554000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-609000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17163000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14091000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,210000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14301000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14301000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14301000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64239000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64239000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65000000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 10:10:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57203000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57203000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2124000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2124000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55079000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24755000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1263000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25443000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51461000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3618000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14842000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1240000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16082000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12464000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1141000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13605000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13605000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13605000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64480000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64480000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64800000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:06:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55147000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55147000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2243000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2243000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52904000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36117000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1476000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25444000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63037000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10133000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12513000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-764000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11749000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1616000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1715000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3331000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3331000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3331000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72747000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72747000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66600000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 08:39:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59225000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59225000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2563000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2563000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56662000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22949000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5574000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,25443000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,189790000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3891000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,247647000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-190985000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39506000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32946000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6560000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-197545000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4919000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-192626000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-192626000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-192626000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70716000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.69
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70716000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.69
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70716000.0
Depomed Inc,ASRT,,0001005201,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.69
